Several studies have shown that human exposure to FLX is associated with rare and delayed hypersensitivity reactions characterized by the recruitment of CD8+ cells to kill the hepatocytes, and favored in individuals carrying HLA-B*57:01 determinant, but at a frequency not exceeding 1/100014, 38. Here, CD8A is linked to type IV hypersensitivity disease.